NCT01041170View on ClinicalTrials.gov

Antagonist-Elicited Cannabis Withdrawal

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

April 16, 2006

Primary Completion Date

January 11, 2010

Study Completion Date

January 11, 2010

Conditions
CannabisDependence
Interventions
DRUG

THC

DRUG

Rimonobant

DRUG

Rimonabant

Trial Locations (2)

21224

National Institute on Drug Abuse, Biomedical Research Center (BRC), Baltimore

21201-1595

University of Maryland, Baltimore, Baltimore

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT01041170 - Antagonist-Elicited Cannabis Withdrawal | Biotech Hunter | Biotech Hunter